Sign in

CIK 0001635088 · Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
operating
EIN
981173944
Phone
441-295-5950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,719,562
in 13 filings, $45.5M under 10b5-1 plans

Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Venker Eric −$43.7M President & Immunovant CEO sold 59% of stake
  2. Sukhatme Mayukh −$27.7M President & CIO sold 4% of stake
  3. Pulik Richard −$12.5M CFO sold 57% of stake
  4. Fitzgerald Meghan −$1.0M Director sold 41% of stake
  5. Epperly Melissa B, −$837K Director sold 60% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-09-18 Gline Matthew CEO Purchase +3,315 $15.07 $50K 17,287,081

Page 1 of 1 · 1 trade